Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Neuropharmacology. 2012 Feb 22;62(7):2429–2438. doi: 10.1016/j.neuropharm.2012.02.017

Figure 2. Post but not presynaptic alterations following WD as measured by Sr2+ substituted aEPSCs.

Figure 2

A1 & A2) A1, Representative traces showing stimulated asynchronous release following Sr2+ substitution (3.0mM) for calcium (2.0mM) that are DNQX sensitive(A2). B) aEPSC event frequency at EC-BLA synapses does not change across treatment conditions (CON, n = 10; CIE n = 13; WD, n = 7). C) aEPSC amplitudes increased during WD compared to CON and CIE conditions (CON, n = 10; CIE, n = 13; WD, n = 7; * = p < 0.01 D) Representative traces showing increased amplitudes during WD compared to control. Dashed lines indicate area included in the analysis.